• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺恶性肿瘤胰十二指肠切除术后的治疗效果、30 天再入院率和医疗资源利用情况。

Treatment outcomes, 30-day readmission and healthcare resource utilization after pancreatoduodenectomy for pancreatic malignancies.

机构信息

Department of Surgery, University of South Carolina, Greenville Health System, 701 Grove Road, Greenville, SC 29605, USA.

Division of Surgical Oncology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

出版信息

J Hepatobiliary Pancreat Sci. 2019 May;26(5):187-194. doi: 10.1002/jhbp.621. Epub 2019 Apr 8.

DOI:10.1002/jhbp.621
PMID:30900403
Abstract

BACKGROUND

We sought to determine treatment outcomes after pancreatoduodenectomy for pancreatic head and uncinate process malignancy and its impact on mortality, morbidity, and resource utilization.

METHODS

This was a retrospective cohort study using the 2014 Nationwide Readmissions Database. Discharges were included if they had an ICD-9 CM procedure code for pancreatoduodenectomy and any code for malignancy of the pancreas head and uncinate process. Independent predictors of readmission were identified using multivariable Cox regression analysis.

RESULTS

A total of 4,445 patients were included. The surgical complication rate was 17.3%, and in-hospital mortality rate was 3%. The 30-day readmission rate was 19.7% with an in-hospital mortality rate of 3.9%. The most common reason for readmission was postoperative infection. The mean length of stay during readmission was 6.50 days, while the mean total hospitalization costs and charges were $15,589 and $52,922, respectively. The number of hospital days associated with readmission was 5,548, with an in-hospital economic burden of $12.9 million (costs) and $43.7 million (charges). Hospital volume and discharge disposition were independent predictors of 30-day readmission.

CONCLUSIONS

Pancreatoduodenectomy for pancreatic malignancies is still associated with significant morbidity, mortality and 30-day readmission. Reducing readmission can impact mortality, quality of life, and healthcare economic burden in this setting.

摘要

背景

我们旨在确定胰头和钩突恶性肿瘤胰十二指肠切除术的治疗结果及其对死亡率、发病率和资源利用的影响。

方法

这是一项使用 2014 年全国再入院数据库的回顾性队列研究。如果出院记录有胰十二指肠切除术的 ICD-9-CM 程序代码和任何胰头和钩突恶性肿瘤代码,则纳入研究。使用多变量 Cox 回归分析确定再入院的独立预测因素。

结果

共纳入 4445 例患者。手术并发症发生率为 17.3%,院内死亡率为 3%。30 天再入院率为 19.7%,院内死亡率为 3.9%。再入院的主要原因是术后感染。再入院期间的平均住院时间为 6.50 天,平均总住院费用和费用分别为 15589 美元和 52922 美元。与再入院相关的住院天数为 5548 天,院内经济负担为 1290 万美元(成本)和 4370 万美元(费用)。医院容量和出院处置是 30 天再入院的独立预测因素。

结论

胰头和钩突恶性肿瘤的胰十二指肠切除术仍然与显著的发病率、死亡率和 30 天再入院率相关。减少再入院可影响该人群的死亡率、生活质量和医疗保健经济负担。

相似文献

1
Treatment outcomes, 30-day readmission and healthcare resource utilization after pancreatoduodenectomy for pancreatic malignancies.胰腺恶性肿瘤胰十二指肠切除术后的治疗效果、30 天再入院率和医疗资源利用情况。
J Hepatobiliary Pancreat Sci. 2019 May;26(5):187-194. doi: 10.1002/jhbp.621. Epub 2019 Apr 8.
2
Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States.美国患者、医生和医院因素对胰十二指肠切除术后 30 天再入院的影响。
JAMA Surg. 2013 Dec;148(12):1095-102. doi: 10.1001/jamasurg.2013.2509.
3
Thirty-Day Readmission Among Patients With Non-Variceal Upper Gastrointestinal Hemorrhage and Effects on Outcomes.非静脉曲张性上消化道出血患者的 30 天再入院率及其对结局的影响。
Gastroenterology. 2018 Jul;155(1):38-46.e1. doi: 10.1053/j.gastro.2018.03.033. Epub 2018 Mar 28.
4
Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal.胰腺癌胰十二指肠切除术后的再入院情况:基于人群的评估。
Ann Surg Oncol. 2009 Mar;16(3):554-61. doi: 10.1245/s10434-008-0178-6. Epub 2008 Nov 11.
5
Readmission and Resource Use After Robotic-Assisted versus Open Pancreaticoduodenectomy: 2010-2017.机器人辅助与开腹胰十二指肠切除术术后再入院和资源利用:2010-2017 年。
J Surg Res. 2020 Nov;255:517-524. doi: 10.1016/j.jss.2020.05.084. Epub 2020 Jul 3.
6
Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?哪些临床和患者因素会影响全关节置换术后再入院的国家经济负担?
Clin Orthop Relat Res. 2017 Dec;475(12):2926-2937. doi: 10.1007/s11999-017-5244-6.
7
Impact of Complications After Pancreatoduodenectomy on Mortality, Organ Failure, Hospital Stay, and Readmission: Analysis of a Nationwide Audit.胰十二指肠切除术后并发症对死亡率、器官衰竭、住院时间和再入院的影响:全国性审计分析。
Ann Surg. 2022 Jan 1;275(1):e222-e228. doi: 10.1097/SLA.0000000000003835.
8
Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients.胰十二指肠切除术后再入院的影响因素:1302 例多机构研究。
Ann Surg. 2012 Sep;256(3):529-37. doi: 10.1097/SLA.0b013e318265ef0b.
9
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.2009 年至 2014 年佛罗里达州慢性阻塞性肺疾病(COPD)患者再入院率、住院费用和死亡率趋势。
Clin Ther. 2018 Apr;40(4):613-626.e1. doi: 10.1016/j.clinthera.2018.03.006. Epub 2018 Mar 31.
10
Specific Medicare Severity-Diagnosis Related Group Codes Increase the Predictability of 30-Day Unplanned Hospital Readmission After Pancreaticoduodenectomy.特定的医疗保险严重程度-诊断相关组代码可提高胰十二指肠切除术后 30 天非计划性住院再入院的可预测性。
J Gastrointest Surg. 2018 Nov;22(11):1920-1927. doi: 10.1007/s11605-018-3879-6. Epub 2018 Jul 23.

引用本文的文献

1
Predictors of Financial Toxicity Trajectories in Patients With Pancreatic Cancer: A Latent Class Growth Analysis.胰腺癌患者财务毒性轨迹的预测因素:潜在类别增长分析
Cancer Med. 2025 May;14(9):e70875. doi: 10.1002/cam4.70875.
2
Systematic Review and Meta-Analysis of the Financial Impact of 30-Day Readmissions for Selected Medical Conditions: A Focus on Hospital Quality Performance.特定医疗状况30天再入院财务影响的系统评价与Meta分析:聚焦医院质量绩效
Healthcare (Basel). 2024 Mar 29;12(7):750. doi: 10.3390/healthcare12070750.
3
Antibiotic prophylaxis after 48 h postoperatively are not associated with decreased surgical site infections and other healthcare associated infections in pancreatic surgery patients: a retrospective cohort study.
术后 48 小时后使用抗生素预防与胰腺手术患者的手术部位感染和其他与医疗保健相关的感染减少无关:一项回顾性队列研究。
Antimicrob Resist Infect Control. 2023 Dec 2;12(1):138. doi: 10.1186/s13756-023-01348-3.
4
Do Weekend Discharges Impact Readmission Rate in Patients Undergoing Pancreatic Surgery?周末出院是否会影响胰腺手术后患者的再入院率?
J Gastrointest Surg. 2023 Dec;27(12):2815-2822. doi: 10.1007/s11605-023-05864-w. Epub 2023 Nov 14.
5
Rectus sheath catheters reduce opiate use in pancreaticoduodenectomy: a pre- and postintervention cohort study.直肠鞘内导管可减少胰十二指肠切除术的阿片类药物使用:一项前后干预队列研究。
Can J Surg. 2023 Jul 13;66(4):E367-E377. doi: 10.1503/cjs.006922. Print 2023 Jul-Aug.
6
Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.利用定量成像技术实现胰腺癌的个性化医疗:放射组学与深度学习应用综述
Cancers (Basel). 2022 Mar 24;14(7):1654. doi: 10.3390/cancers14071654.
7
Systematic review of the predictors of health service use in pancreatic cancer.胰腺癌医疗服务利用预测因素的系统评价。
Am J Cancer Res. 2022 Feb 15;12(2):622-650. eCollection 2022.
8
The Severity of Postoperative Pancreatic Fistula Predicts 30-Day Unplanned Hospital Visit and Readmission after Pancreaticoduodenectomy: A Single-Center Retrospective Cohort Study.术后胰瘘的严重程度可预测胰十二指肠切除术后30天内的非计划性医院就诊和再入院:一项单中心回顾性队列研究。
Healthcare (Basel). 2022 Jan 8;10(1):126. doi: 10.3390/healthcare10010126.
9
Gut microbiota patterns associated with somatostatin in patients undergoing pancreaticoduodenectomy: a prospective study.胰十二指肠切除术后患者中与生长抑素相关的肠道微生物群模式:一项前瞻性研究。
Cell Death Discov. 2020 Sep 28;6(1):94. doi: 10.1038/s41420-020-00329-4. eCollection 2020.
10
Minimally invasive surgery for pancreatic cancer.胰腺癌的微创外科手术。
Surg Today. 2021 Feb;51(2):194-203. doi: 10.1007/s00595-020-02120-5. Epub 2020 Aug 28.